FDA Hits Two API Firms With Warning Letters for Data Integrity, Misbranding

Drug Industry Daily
A A
The FDA has issued warning letters to two API manufacturers, citing branding and data integrity issues.

To View This Article:

Login

Subscribe To Drug Industry Daily